It is difficult to comprehend, why the Obama administration, which has made cost-cutting a legislative centerpiece of healthcare reform, would remove the most potent, financial penalty in its existing legal arsenal from its settlement with Pfizer.
Pfizer, the world’s largest drug manufacturer has the dubious distinction of being a corporate "repeat offender…"
“I was trained from day one to market the drug illegally…My job was to promote Neurontin and motivate doctors to experiment on patients. After being hired as a medical liaison, I was selling drugs. The uses promoted were from the “snake-oil list” of 13 medical conditions."
A U.S. federal judge has issued an order to unseal thousands of Wyeth Pharmaceutical documents that provide details about the company’s "mammoth" ghostwriting campaign.
“Every failure-to-warn case against a drug company has been affected by Wyeth”
"The strategy of big companies when they are dealing with smaller opponents is to stretch the process, to overwhelm us until we are ready to accept whatever they want to offer."
A series of slides, all prepared by Dr. Biederman–according to his sworn testimony–are revealing as they raise serious doubts about the scientific and ethical integrity of his oeuvre.
Like their benefactors–drug manufacturers–who violate the law, doctors will be prosecuted in court by the federal government.
Since 2006, the results of a multi-site clinical trial (MIST) that tested a surgical device have been at the center of dispute among cardiologists on both sides of the Atlantic.
A document filed in Federal District Court, Orlando Fla, by plaintiffs "in response to AstraZeneca’s motion to exclude evidence and argument about Dr. Macfadden’s personal relationships," sheds light on yet another facet of manipulation–sexual exploitation.
Despite Lilly's efforts to suppress the documents, they are available on internet websites.
Judge Jack Weinstein rejected Lilly's effort to seek a court injunction against internet posting
of the documents.
A federal Judge of the Eastern District (Brooklyn) issued a ruling upholding a seal on documents that contain evidence linking Zyprexa, Eli Lilly's antipsychotic drug to diabetes
